Lilburn’s 2024 Medicaid spending on COVID-19 services tops $33,108

Dr. Mehmet Oz CMS Administrator
Dr. Mehmet Oz CMS Administrator
0Comments

At least $33,108 in Medicaid payments were recorded in Lilburn in 2024 for services billed under HCPCS codes specifically tied to COVID-19, based on data from the U.S. Department of Health and Human Services Medicaid Provider Spending database.

Medicaid, a public health insurance initiative run by each state and funded through a federal-state partnership, provides coverage for low-income individuals, elderly adults, children, and people with disabilities and represents a substantial component of the nation’s health system.

Because the Medicaid program is funded by taxpayers, local Medicaid billing levels highlight how health care dollars are distributed within a community.

For this analysis, services considered related to COVID-19 were identified using HCPCS codes labeled or referenced as “COVID-19” or “coronavirus”-specific in the billing or reference data. As a result, the totals include only services explicitly coded as COVID-related and exclude care for the pandemic that may have been billed under more general or different codes.

Dalton reported the highest amount of Medicaid payments linked to COVID-19 care in Georgia for 2024, reporting $147,318 in relevant claims.

To provide context, Medicaid providers in Lilburn saw an average COVID-19–related payment per provider of $16,554, which falls below the overall Georgia state average of $17,922.

COVID-19–specific services comprised a noticeable portion of Lilburn’s Medicaid spending growth during the pandemic.

In the two years before the start of the pandemic, Lilburn’s average annual Medicaid payments were $611,627.

The Centers for Medicare & Medicaid Services reports that combined state and federal Medicaid expenditures hit approximately $871.7 billion in fiscal year 2023—about 18% of total national health spending—up sharply from $613.5 billion in 2019, prior to the COVID-19 pandemic.

This growth—nearly 40%—reflects expanded enrollment as well as high utilization during and after the pandemic phase.

Major federal budget bills under the Trump administration have proposed deep reductions and restructuring of Medicaid funding. One example is the “One Big Beautiful Bill Act,” signed in 2025, which is projected to eliminate over $1 trillion from federal Medicaid expenditures over a decade, imposing changes such as work requirements and cost-sharing. These adjustments could limit Medicaid coverage and financing for certain recipients, shift greater costs to states, and constrain future federal spending, even as the program continues to help tens of millions nationwide.

Medicaid Payments in Lilburn Over 7 Years
Year COVID-19–Related Payments COVID-19 Payments % Change (YoY) Total Medicaid Payments
2024 $33,108 -21.8% $514,366
2023 $42,345 -18.3% $1,004,583
2022 $51,822 184.7% $1,561,081
2021 $18,203 N/A $1,078,038
2020 $0 N/A $458,738
2019 $0 N/A $525,177
2018 $0 N/A $698,077
Top COVID-19–Related HCPCS Codes in Lilburn
HCPCS Code Description Medicaid Payments Claims
87811 Immunoassay $33,108 810

Note: Includes only HCPCS codes explicitly designated for COVID-19 services; figures do not reflect all care related to the pandemic.

The information in this article comes from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The underlying dataset is available here.



Related

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

How many companies in cities across Gwinnett County received FDA citations in Q1?

There were two companies in cities associated with Gwinnett County that received FDA citations as a result of two inspections conducted in the county over the first quarter of 2026, according to reports from the U.S. Food and Drug Administration (FDA).

Sridhar Mantha, Acting Chief Information Officer of FDA

Cities located in Gwinnett County saw FDA inspections of 11 companies in Q1

There were 11 companies in cities associated with Gwinnett County that received 11 FDA inspections in the first quarter of 2026, according to the U.S. Food and Drug Administration.

Kyle Diamantas, J.D., Deputy Commissioner for Human Foods of FDA

Valentine Enterprises, Inc. in Lawrenceville reviewed by FDA on Feb. 6

Valentine Enterprises, Inc. in Lawrenceville underwent a Feb. 6 inspection by the FDA focused on food composition, standards, labeling and economics, as reflected in data on the FDA website.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from South Gwinnett News.